An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine

Author: Bruce Y. Lee, MD, MBA, Sarah M. Bartsch, MPH, Mercy Mvundura, PhD, Courtney Jarrahian, Kristina M. Zapf, MPH, Kathleen Marinan, Angela R. Wateska, MPH, Bill Snyder, JD, LLM, Savitha Swaminathan, Erica Jacoby, James J. Norman, PhD, Mark R. Prausnitz, PhD, and Darin Zehrung


New vaccine technologies may improve the acceptability, delivery (potentially enabling self-administration), and product efficacy of influenza vaccines. One such technology is the microneedle patch (MNP), a skin delivery technology currently in development. Although MNPs hold promise in preclinical studies, their potential economic and epidemiologic impacts have not yet been evaluated.


Type Journal article
Language English
Country Not Specified
Journal Vaccine
Volume 33
Publisher Elsevier
Year 2015
Disease , Influenza , influenza vaccination , Influenza vaccine , Microneedle
Added by Marilyn Kelly
Added on 23 February 2017 10:31:11
Hits: 611
Rating Summary:
0 based on 0 votes
Add to Favourites